Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Johnson Chemical Pharmaceutical Works Co., Ltd. (4747:TWSE), powered by AI.
Johnson Chemical Pharmaceutical Works Co., Ltd. is currently trading at $53.70. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Johnson Chemical Pharmaceutical Works Co., Ltd. on Alpha Lenz.
View Johnson Chemical Pharmaceutical Works Co., Ltd.'s valuation metrics on Alpha Lenz.
“Johnson Chemical Pharmaceutical Works Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.”
Ask for details →Johnson Chemical Pharmaceutical Works Co., Ltd. is a pharmaceutical manufacturer specializing in the development and production of a broad array of therapeutic drugs. Established in 1959 and headquartered in New Taipei City, Taiwan, the company focuses on essential sectors within the healthcare industry, including pharmaceuticals targeting the central nervous system, respiratory and cardiovascular systems, gastrointestinal health, endocrine disorders, as well as vitamins and anti-inflammatory agents. Its offerings encompass various dosage forms, such as soft and hard capsules, coated and uncoated tablets, powders, granules, suppositories, and nasal sprays. Serving primarily the Taiwanese and broader Asian markets, Johnson Chemical Pharmaceutical Works is recognized for supplying both finished medications and pharmaceutical raw materials. With a workforce of over 170 employees, the company contributes significantly to the supply of generic and specialty medicines, supporting healthcare infrastructure across the region. Johnson Chemical Pharmaceutical Works Co., Ltd. plays a vital role in ensuring accessibility to a wide spectrum of medications, reflecting its longstanding presence and expertise in the pharmaceutical manufacturing landscape.
“Johnson Chemical Pharmaceutical Works Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.”
Ask for details →Johnson Chemical Pharmaceutical Works Co., Ltd. (ticker: 4747) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 170 employees.
The current price is 53.7 with a P/E ratio of -x and P/B of -x.
ROE is 3.13% and operating margin is 12.83%. Annual revenue is $570M.